Prexasertib Mesylate Hydrate

Modify Date: 2024-01-12 10:55:27

Prexasertib Mesylate Hydrate Structure
Prexasertib Mesylate Hydrate structure
Common Name Prexasertib Mesylate Hydrate
CAS Number 1234015-57-6 Molecular Weight 479.51
Density N/A Boiling Point N/A
Molecular Formula C19H25N7O6S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Prexasertib Mesylate Hydrate


Prexasertib Mesylate Hydrate (LY2606368 Mesylate Hydrate) is a potent, selective, ATP competitive CHK1 and CHK2 inhibitor, with a Ki of 0.9 nM for CHK1 and IC50s of <1 nM, 8 nM for CHK1 and CHK2, respectively. Prexasertib Mesylate Hydrate inhibits HT-29 CHK1 autophosphorylation (S296) and HT-29 CHK2 autophosphorylation (S516). Prexasertib Mesylate Hydrate shows potent anti-tumor activity, significantly abrogates the G2/M checkpoint in p53 deficient HeLa cells with an EC50 of 9 nM[1].

 Names

Name Prexasertib Mesylate Hydrate
Synonym More Synonyms

 Prexasertib Mesylate Hydrate Biological Activity

Description Prexasertib Mesylate Hydrate (LY2606368 Mesylate Hydrate) is a potent, selective, ATP competitive CHK1 and CHK2 inhibitor, with a Ki of 0.9 nM for CHK1 and IC50s of <1 nM, 8 nM for CHK1 and CHK2, respectively. Prexasertib Mesylate Hydrate inhibits HT-29 CHK1 autophosphorylation (S296) and HT-29 CHK2 autophosphorylation (S516). Prexasertib Mesylate Hydrate shows potent anti-tumor activity, significantly abrogates the G2/M checkpoint in p53 deficient HeLa cells with an EC50 of 9 nM[1].
Related Catalog
Target

Chk1:0.9 nM (Ki)

Chk1:<1 nM (IC50)

Chk2:8 nM (IC50)

In Vitro Prexasertib Mesylate Hydrate (LY2606368 Mesylate Hydrate) is an ATP competitive CHK1 inhibitor, with a Ki of 0.9 nM and an IC50 of <1 nM[1]. Prexasertib (LY2606368) shows high anti-tumor activity against U-2 OS, Calu-6 and HeLa cells (IC50, 3, 3, 37 nM, respectively), causes DNA damage during S-phase requiring CDC25A and CDK2 at 4 μM[1]. Prexasertib (0-20 nM) synergizes with olaparib (0-20 μM) to decrease cell viability in HGSOC cells[2].
Animal Admin Prexasertib (1, 3.3 or 10 mg/kg s.c.) is well tolerated, and significantly inhibits tumor inhibition in mice bearing Calu-6 xenograft tumors[1].
References

[1]. King C, et al. LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms. Mol Cancer Ther. 2015 Sep;14(9):2004-13.

[2]. Brill E, et al. Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer. Oncotarget. 2017 Oct 31;8(67):111026-111040.

 Chemical & Physical Properties

Molecular Formula C19H25N7O6S
Molecular Weight 479.51
Storage condition 2-8℃

 Synonyms

Prexasertib (Mesylate Hydrate)
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

Prexasertib Mesylate Hydrate suppliers


Price: ¥1300/5 mg

Reference only. check more Prexasertib Mesylate Hydrate price